Return On Equity of Tracon Pharmaceuticals, Inc. from 30 Sep 2015 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tracon Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 30 Jun 2024.
  • Tracon Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Jun 2024 was -238%, a 177% decline year-over-year.
  • Tracon Pharmaceuticals, Inc. annual Return On Equity for 2023 was 47%, a 98% decline from 2022.
  • Tracon Pharmaceuticals, Inc. annual Return On Equity for 2022 was 2617%.
  • Tracon Pharmaceuticals, Inc. annual Return On Equity for 2021 was -182%, a 26% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Tracon Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 -238% -546% -177% 01 Apr 2024 30 Jun 2024
Q1 2024 -33% -648% -105% 01 Jan 2024 31 Mar 2024
Q4 2023 47% -2570% -98% 01 Oct 2023 31 Dec 2023
Q3 2023 119% +948% 01 Jul 2023 30 Sep 2023
Q2 2023 308% +647% 01 Apr 2023 30 Jun 2023
Q1 2023 615% +907% 01 Jan 2023 31 Mar 2023
Q4 2022 2617% +2799% 01 Oct 2022 31 Dec 2022
Q3 2022 -829% -696% -525% 01 Jul 2022 30 Sep 2022
Q2 2022 -338% -216% -176% 01 Apr 2022 30 Jun 2022
Q1 2022 -292% -181% -162% 01 Jan 2022 31 Mar 2022
Q4 2021 -182% -38% -26% 01 Oct 2021 31 Dec 2021
Q3 2021 -133% +141% +52% 01 Jul 2021 30 Sep 2021
Q2 2021 -123% +440% +78% 01 Apr 2021 30 Jun 2021
Q1 2021 -112% +311% +74% 01 Jan 2021 31 Mar 2021
Q4 2020 -145% +153% +51% 01 Oct 2020 31 Dec 2020
Q3 2020 -274% -58% -27% 01 Jul 2020 30 Sep 2020
Q2 2020 -563% -398% -241% 01 Apr 2020 30 Jun 2020
Q1 2020 -423% -290% -218% 01 Jan 2020 31 Mar 2020
Q4 2019 -298% -190% -176% 01 Oct 2019 31 Dec 2019
Q3 2019 -215% -107% -99% 01 Jul 2019 30 Sep 2019
Q2 2019 -165% -85% -107% 01 Apr 2019 30 Jun 2019
Q1 2019 -133% -50% -61% 01 Jan 2019 31 Mar 2019
Q4 2018 -108% -11% -12% 01 Oct 2018 31 Dec 2018
Q3 2018 -108% -25% -30% 01 Jul 2018 30 Sep 2018
Q2 2018 -80% +40% +34% 01 Apr 2018 30 Jun 2018
Q1 2018 -82% +44% +35% 01 Jan 2018 31 Mar 2018
Q4 2017 -97% +24% +20% 01 Oct 2017 31 Dec 2017
Q3 2017 -83% +54% +39% 01 Jul 2017 30 Sep 2017
Q2 2017 -120% -7.9% -7.1% 01 Apr 2017 30 Jun 2017
Q1 2017 -127% -52% -70% 01 Jan 2017 31 Mar 2017
Q4 2016 -121% -62% -107% 01 Oct 2016 31 Dec 2016
Q3 2016 -138% -77% -126% 01 Jul 2016 30 Sep 2016
Q2 2016 -112% 01 Apr 2016 30 Jun 2016
Q1 2016 -75% 01 Jan 2016 31 Mar 2016
Q4 2015 -58% 01 Oct 2015 31 Dec 2015
Q3 2015 -61% 01 Jul 2015 30 Sep 2015

Tracon Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 47% -2570% -98% 01 Jan 2023 31 Dec 2023
2022 2617% +2799% 01 Jan 2022 31 Dec 2022
2021 -182% -38% -26% 01 Jan 2021 31 Dec 2021
2020 -145% +153% +51% 01 Jan 2020 31 Dec 2020
2019 -298% -190% -176% 01 Jan 2019 31 Dec 2019
2018 -108% -11% -12% 01 Jan 2018 31 Dec 2018
2017 -97% +24% +20% 01 Jan 2017 31 Dec 2017
2016 -121% -63% -108% 01 Jan 2016 31 Dec 2016
2015 -58% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.